Loading clinical trials...
Loading clinical trials...
Treatment of Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia by Chimeric Antigen Receptor (CAR)-Modified T Cells
Conditions
Interventions
CAR-T cells
Locations
1
China
Department of Hematopoietic Stem Cell Transplantation
Beijing, China
Start Date
July 1, 2016
Primary Completion Date
October 1, 2021
Completion Date
December 1, 2021
Last Updated
February 10, 2021
NCT05376111
NCT04065399
NCT05453500
NCT07295951
NCT03970096
NCT05442515
Lead Sponsor
Affiliated Hospital to Academy of Military Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions